Your Dose of Cannabis Education
Your Dose of Cannabis Education
Only have a minute but want to Learn something every day™? Sign up to receive Your Dose of Cannabis Education, bringing featured content from our course library right to your inbox each day.
Your Dose of Cannabis Education is based on data from the studies and reviews published in the current peer-reviewed medical journals. Whether you are a healthcare provider, patient, caregiver, an individual working in the healthcare sector, or just a curious person, you can benefit from Your Dose of Cannabis Education.
Wake up every morning and get your dose of unbiased evidence-based cannabis education!
2025-12-11
Are there any possible detrimental effects of combining cannabis while undergoing immunotherapy?
"Recent data indicate that there could also be a detrimental effect of combining cannabis while undergoing immunotherapy, which may be related to the anti-inflammatory effects of cannabis, similar to the use of steroids during immunotherapy. These preliminary reports provide important questions about the risks associated with cannabis use during active cancer treatment."Gowin K, Muminovic M, Zick S, et al. Integrative Therapies in Cancer Care: An Update on the Guidelines. ASCO Educational Book (asco.ord/edbook) Vol 44, Iss 3. Mar 31 2024.
2025-12-10
CB2 receptors are expressed throughout the immune system and are found in several other systems. What activities do CB2 receptors modulate in systems other than the immune system?
"While CB2 receptors are primarily expressed by immune cells in the body, they are also found in other tissues, including the gastrointestinal tract, hematopoietic cells, bone, reproductive system, and cardiovascular system. In the brain, CB2 expression is increased in areas associated with neurodegeneration and is thought to be involved in the regulation of neuroinflammation. In the gastrointestinal tract, CB2 activation has been shown to reduce inflammation and improve appetite. In the cardiovascular system, CB2 activation has been linked to improved blood pressure, lipid levels, and glucose metabolism."Wilson G, Yang L, Su X, Ding S, Li L, Yang Y, Wang X, Wang W, Sa Y, Zhang Y, Chen J, Ma X. Exploring the therapeutic potential of natural compounds modulating the endocannabinoid system in various diseases and disorders: review. Pharmacological Reports. 31 Oct 2023
2025-12-09
Has the American Society of Clinical Oncology made any recommendations concerning the use of cannabinoids as a cancer-directed treatment?
Yes, according to the article 'Integrative Therapies in Cancer Care: An Update on the Guidelines,' "Clinicians should recommend against using cannabis or cannabinoids as a cancer-directed treatment unless within the context of a clinical trial." Also, "clinicians should recommend against use of cannabis and/or cannabinoids in place of cancer- directed treatment." Gowin K, Muminovic M, Zick S, et al. Integrative Therapies in Cancer Care: An Update on the Guidelines. ASCO Educational Book (asco.ord/edbook) Vol 44, Iss 3. Mar 31 2024.
2025-12-08
What is the half life of CBD? How does it compare to the half life of THC?
The half life of CBD is 18-32 hours, which is similar to the half life of THC of 20-30 hours. Both CBD and THC are distributed to fatty tissues and highly perfused organs such as brain, heart, lung, and liver.Page II RL , Allen LA , Kloner RA , Carriker CR , Martel C , Morris AA , Piano MR , Rana JS , Saucedo JF, et al. Medical Marijuana, Recreational Cannabis, and Cardiovascular Health: A Scientific Statement From the American Heart Association - Originally published5 Aug 2020https://doi.org/10.1161/CIR.0000000000000883Circulation. 2020;142:e131–e152
2025-12-05
Cannabis products purchased at a medical dispensary and over the counter CBD products are not FDA-approved. Does the FDA accept adverse event reports associated with the cannabinoid products?
Yes. "Consumers and healthcare providers can report adverse events associated with cannabis or cannabis-derived products via the FDA’s MedWatch reporting system, either on the FDA website (MedWatch: The FDA Safety Information and Adverse Event Reporting Program webpage) or by phone at 1-800-FDA-1088." https://www.fda.gov/news-events/public-health-focus/fda-regulation-cannabis-and-cannabis-derived-products-including-cannabidiol-cbd#:~:text=Consumers%20and%20healthcare%20providers%20can,%2D800%2DFDA%2D1088.
Learn something every day™ in your 
feed…
Our courses
CBD in Clinical Care V2
A Nationally Approved CME/CE Medical Marijuana Course V2
Cannabis Essentials CME/CE Bundle
New to TheAnswerPage? There’s lots we’d like to share with you and we don’t want you to miss a thing! Be sure to register today for “Your Dose of Cannabis Education” emails where you’ll gain valuable insights in small doses that fit your schedule and also be provided direct access to the archived daily content.